Detalles de la búsqueda
1.
Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis
; 16: 495-498, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33688175
2.
Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin.
Antimicrob Resist Infect Control
; 9(1): 116, 2020 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32723393
3.
Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations.
Respir Med
; 154: 27-33, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31203097
4.
Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by KRAS G12C Mutation: A Report of Two Cases.
JCO Precis Oncol
; 7: e2300451, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096473
5.
Occurrence of virus-induced COPD exacerbations during four seasons.
Infect Dis (Lond)
; 47(2): 96-100, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25426994
6.
Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
Lancet Respir Med
; 2(5): 361-8, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24746000
7.
Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.
Trials
; 13: 82, 2012 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-22682323
Resultados
1 -
7
de 7
1
Próxima >
>>